Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.64
Delayed Data
As of Feb 09
 +0.025 / +0.96%
Today’s Change
2.52
Today|||52-Week Range
5.30
-45.45%
Year-to-Date

Today’s Trading

Previous close2.62
Today’s open2.56
Day’s range2.52 - 2.74
Volume2,458,546
Average volume (3 months)2,907,435
Market cap$413.8M
Dividend yield--
Data as of 02/09/2016

Growth & Valuation

Earnings growth (last year)+23.33%
Earnings growth (this year)+101.74%
Earnings growth (next 5 years)--
Revenue growth (last year)-10.13%
P/E ratioNM
Price/Sales432.79
Price/Book3.15

Competitors

 Today’s
change
Today’s
% change
--Quidel Corp-0.14-0.97%
NTRANatera Inc+0.05+0.76%
QDELQuidel Corp-0.81-4.96%
OXFDOxford Immunotec Glo...+0.10+0.96%
Data as of 02/09/2016

Financials

Next reporting dateMarch 8, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$1.2M
Annual profit (last year)-$35.7M
Net profit margin-3,093.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers